Capricor Therapeutics
CAPR
#7318
Rank
HK$4.49 B
Marketcap
HK$77.25
Share price
9.44%
Change (1 day)
78.67%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2023 (TTM): -HK$9.17

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$19.22. In 2022 the company made an earnings per share (EPS) of -HK$9.25 a decrease over its 2021 EPS that were of -HK$6.82.

EPS history for Capricor Therapeutics from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$9.17-0.93%
2022-HK$9.2535.63%
2021-HK$6.82-7.45%
2020-HK$7.37-55.45%
2019-HK$16.55-59.81%
2018-HK$41.18-1850%
2017HK$2.35-102.94%
2016-HK$80.0025.93%
2015-HK$63.5355.77%
2014-HK$40.78-39.53%
2013-HK$67.45-64.78%
2012-HK$191.48-62.44%
2011-HK$509.79-31.58%
2010-HK$745.08-38.71%
2009-HK$1,216-43.64%
2008-HK$2,157-5.17%
2007-HK$2,274427.27%
2006-HK$431.36340.33%
2005-HK$97.96
2004N/A
2003N/A
2002N/A
2001N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.43-372.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$55.29-387.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-HK$56.63 194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.12 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$59.21 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$229.72 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA